Skip to search formSkip to main contentSkip to account menu

lusutrombopag

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

CinnamatesThiazoles

Narrower (1)

Mulpleta

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
New thrombopoietin receptor agonist (Lusutrombopag) is more effective in impaired renal function patients with chronic liver disease.
BACKGROUND Thrombopoietin (TPO) receptor agonist, Lusutrombopag, is recently released to treat thrombocytopenia in chronic liver… 
2020
2020
Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS
Lusutrombopag is a second oral thrombopoietin (TPO) receptor agonist that selectively acts on human TPO receptors. In the study… 
2020
2020
Lusutrombopag for Severe Thrombocytopenia in Patients with Hepatocellular Carcinoma
Thrombopoietin receptor agonists, such as lusutrombopag, have been shown to be effective in improving platelet counts in… 
2019
2019
Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance
Lusutrombopag is approved for the treatment of thrombocytopenia in chronic liver disease patients undergoing invasive procedures… 
2019
2019
PF697 LUSUTROMBOPAG IS A SAFE AND EFFICACIOUS TREATMENT OPTION FOR THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING PLANNED INVASIVE PROCEDURES: INTEGRATED ANALYSIS OF TWO PHASE 3…
2018
2018
Lusutrombopag as pretreatment for liver biopsy following liver transplantation
In patients who have undergone liver transplantation (LT) for liver cirrhosis, low platelet count due to hypersplenism may… 
2017
2017
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
A 56-year-old Japanese man with liver cirrhosis (LC) due to hepatitis C virus was admitted to our hospital for radiofrequency… 
2017
2017
Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization.
Lusutrombopag, a small molecule thrombopoietin receptor agonist, has been approved for the treatment of chronic liver disease… 
2017
2017
Avoidance of platelet transfusion with readministration of lusutrombopag before radiofrequency ablation in hepatocellular carcinoma:a case report.
Platelet transfusions are generally administered to patients with liver cirrhosis and associated thrombocytopenia before… 
2014
2014
P933 ONCE-DAILY ORAL LUSUTROMBOPAG, ALTERNATIVE TO PLATELET TRANSFUSION IN THROMBOCYTOPENIC PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING RADIOFREQUENCY ABLATION: RESULTS FROM A PHASE 2B, RANDOMIZED…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)